- Home
- XERS vs OSPN Comparison
XERS vs OSPN Comparison
Compare XERS & OSPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- OSPN
- Stock Information
- Founded
- XERS 2005
- OSPN 1991
- Country
- XERS United States
- OSPN United States
- Employees
- XERS N/A
- OSPN N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- OSPN EDP Services
- Sector
- XERS Health Care
- OSPN Technology
- Exchange
- XERS Nasdaq
- OSPN Nasdaq
- Market Cap
- XERS 628.7M
- OSPN 549.4M
- IPO Year
- XERS 2018
- OSPN 1998
- Fundamental
- Price
- XERS $5.06
- OSPN $15.73
- Analyst Decision
- XERS Strong Buy
- OSPN Strong Buy
- Analyst Count
- XERS 6
- OSPN 2
- Target Price
- XERS $6.25
- OSPN $19.50
- AVG Volume (30 Days)
- XERS 2.2M
- OSPN 454.1K
- Earning Date
- XERS 05-08-2025
- OSPN 05-01-2025
- Dividend Yield
- XERS N/A
- OSPN 1.51%
- EPS Growth
- XERS N/A
- OSPN N/A
- EPS
- XERS N/A
- OSPN 1.48
- Revenue
- XERS $222,551,000.00
- OSPN $241,702,000.00
- Revenue This Year
- XERS $33.96
- OSPN $4.23
- Revenue Next Year
- XERS $19.87
- OSPN $5.09
- P/E Ratio
- XERS N/A
- OSPN $10.77
- Revenue Growth
- XERS 29.88
- OSPN N/A
- 52 Week Low
- XERS $1.96
- OSPN $12.28
- 52 Week High
- XERS $6.07
- OSPN $20.37
- Technical
- Relative Strength Index (RSI)
- XERS 54.35
- OSPN 52.45
- Support Level
- XERS $4.71
- OSPN $15.67
- Resistance Level
- XERS $5.09
- OSPN $16.10
- Average True Range (ATR)
- XERS 0.22
- OSPN 0.39
- MACD
- XERS -0.00
- OSPN -0.04
- Stochastic Oscillator
- XERS 58.93
- OSPN 35.71
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About OSPN OneSpan Inc.
OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. Its solutions secure and manage access to digital assets and protect online transactions, via mobile devices and in-person. Authentication and anti-fraud solutions are the organization's primary product offerings and include multifactor authentication and virtual private network access capabilities. The company derives revenues from hardware and license fees, maintenance and support fees, and subscription fees. A large majority of the firm's revenue is generated in Europe, the Middle East, and Africa, and the rest in the United States and Asia-Pacific region.